Applications of nanoparticle systems in gene delivery and gene therapy
Source abstract
Abstract
For successful gene therapy, expansion of appropriate gene delivery systems could be one of the factors of major significance. Gene therapy provides large opportunities for treating diseases, including genetic disorders, infections, and cancer. Polymeric carriers have relatively low cytotoxicity and immunogenicity. Polymeric gene carriers are a potential substitute to using viral vectors. Overall, polymeric carriers can contain large-sized DNA, be conjugated with suitable functionalities, and be administered frequently. However, polymeric gene carriers have some restrictions, such as low gene transfection efficiencies and a moderately short period of gene expression. This study explores the current status of development of polymeric gene carriers, and presents guidelines for the prospective use of the polymer-based gene delivery systems in gene therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Department of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
School of Mechanical Engineering, Yeungnam University, Gyeongsan, South Korea
References (85)
Show source-provided references
1. 10.1089/hum.1996.7.16-194710.1089/hum.1996.7.16-1947 ↗
2. 10.1016/S0168-3659(98)00017-010.1016/S0168-3659(98)00017-0 ↗
3. 10.1016/j.addr.2007.04.00710.1016/j.addr.2007.04.007 ↗
4. Anajwala CC · Int J Pharm Sci Nanotechnol · 2010 · 3 · 1043
5. 10.1016/S0022-2836(64)80115-710.1016/S0022-2836(64)80115-7 ↗
6. 10.1002/bit.2039310.1002/bit.20393 ↗
7. 10.1016/S0168-3659(01)00311-X10.1016/S0168-3659(01)00311-X ↗
8. 10.1021/bc700388u10.1021/bc700388u ↗
9. 10.1089/ten.2005.11.119810.1089/ten.2005.11.1198 ↗
10. 10.2147/NSA.S370710.2147/NSA.S3707 ↗
11. 10.1089/1043034995001669010.1089/10430349950016690 ↗
12. 10.1089/1043034995001766210.1089/10430349950017662 ↗
13. 10.1016/j.addr.2006.03.00110.1016/j.addr.2006.03.001 ↗
14. 10.1021/cr030698+10.1021/cr030698+ ↗
15. 10.1023/A:101587412186010.1023/A:1015874121860 ↗
16. 10.3390/1001003410.3390/10010034 ↗
17. 10.1016/j.addr.2011.12.00910.1016/j.addr.2011.12.009 ↗
18. 10.1517/17425247.4.4.40310.1517/17425247.4.4.403 ↗
19. 10.1002/1521-2254(200009/10)2:5<368::AID-JGM118>3.0.CO;2-F10.1002/1521-2254(200009/10)2:5<368::AID-JGM118>3.0.CO;2-F ↗
20. 10.1038/sj.gt.330050310.1038/sj.gt.3300503 ↗
21. 10.1002/(SICI)1521-3773(19990401)38:7<884::AID-ANIE884>3.0.CO;2-K10.1002/(SICI)1521-3773(19990401)38:7<884::AID-ANIE884>3.0.CO;2-K ↗
22. 10.1126/science.813483410.1126/science.8134834 ↗
23. Gasco MR. 1993. Method for producing solid lipid microspheres having a narrow size distribution. Google Patents.
24. 10.1016/j.addr.2008.03.01610.1016/j.addr.2008.03.016 ↗
25. 10.1038/nrg157710.1038/nrg1577 ↗
26. 10.1002/9781118523025.ch1410.1002/9781118523025.ch14 ↗
27. 10.1111/j.1747-0285.2005.00324.x10.1111/j.1747-0285.2005.00324.x ↗
28. 10.1006/mthe.2000.014210.1006/mthe.2000.0142 ↗
29. 10.1038/sj.gt.330166510.1038/sj.gt.3301665 ↗
30. 10.1021/ja00048a00910.1021/ja00048a009 ↗
31. 10.1016/j.progpolymsci.2007.05.01910.1016/j.progpolymsci.2007.05.019 ↗
32. 10.1021/ja021096v10.1021/ja021096v ↗
33. 10.1007/978-1-59745-483-4_3410.1007/978-1-59745-483-4_34 ↗
34. 10.1007/s11095-005-7148-510.1007/s11095-005-7148-5 ↗
35. 10.1093/nar/28.10.e4510.1093/nar/28.10.e45 ↗
36. 10.1002/mnfr.20100031010.1002/mnfr.201000310 ↗
37. 10.1134/S181123821207003X10.1134/S181123821207003X ↗
38. 10.1002/jps.2021610.1002/jps.20216 ↗
39. Kaul G. · Tumor-targeted gene delivery using poly (ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. Pharm Res · 2005 · 22 · 951
40. 10.1002/adfm.20080184410.1002/adfm.200801844 ↗
41. 10.1016/j.jconrel.2005.04.01610.1016/j.jconrel.2005.04.016 ↗
42. 10.18388/abp.2001_512710.18388/abp.2001_5127 ↗
43. 10.1021/bc000063710.1021/bc0000637 ↗
44. 10.1016/S0378-5173(99)00435-410.1016/S0378-5173(99)00435-4 ↗
45. 10.1056/NEJM19950928333130210.1056/NEJM199509283331302 ↗
46. Krebs MD · J Biomed Mater Res Part A · 2010 · 92 · 113110.1002/jbm.a.32441 ↗
47. 10.1016/j.addr.2008.11.00210.1016/j.addr.2008.11.002 ↗
48. 10.1023/A:101642010254910.1023/A:1016420102549 ↗
49. 10.1007/s11095-004-9003-510.1007/s11095-004-9003-5 ↗
50. 10.3109/1061186990908549810.3109/10611869909085498 ↗
51. 10.1021/ja020200610.1021/ja0202006 ↗
52. 10.1016/j.addr.2007.03.01210.1016/j.addr.2007.03.012 ↗
53. 10.1021/ja015556g10.1021/ja015556g ↗
54. 10.1016/S0169-409X(01)00105-310.1016/S0169-409X(01)00105-3 ↗
55. 10.1096/fj.03-1171rev10.1096/fj.03-1171rev ↗
56. 10.1023/A:101421263056610.1023/A:1014212630566 ↗
57. 10.1038/382607a010.1038/382607a0 ↗
58. 10.1021/ma00035a01710.1021/ma00035a017 ↗
59. 10.1016/0378-5173(96)04539-510.1016/0378-5173(96)04539-5 ↗
60. 10.1016/S0939-6411(00)00087-410.1016/S0939-6411(00)00087-4 ↗
61. 10.1038/sj.gt.330090010.1038/sj.gt.3300900 ↗
62. 10.1016/S0169-409X(02)00228-410.1016/S0169-409X(02)00228-4 ↗
63. 10.1016/j.addr.2006.03.00710.1016/j.addr.2006.03.007 ↗
64. 10.1089/10763270432279193410.1089/107632704322791934 ↗
65. 10.1021/bc025529v10.1021/bc025529v ↗
66. 10.1016/1045-1056(95)90004-710.1016/1045-1056(95)90004-7 ↗
67. 10.1016/j.jconrel.2009.12.00610.1016/j.jconrel.2009.12.006 ↗
68. 10.1056/NEJM19900830323090410.1056/NEJM199008303230904 ↗
69. 10.1126/science.112555910.1126/science.1125559 ↗
70. 10.1021/bc015545c10.1021/bc015545c ↗
71. 10.1038/gt.2008.10510.1038/gt.2008.105 ↗
72. Schmidt P. · Pharm Unserer Zeit · 1997 · 26 · 323
73. 10.1016/0168-3659(94)90047-710.1016/0168-3659(94)90047-7 ↗
74. 10.1016/0378-5173(86)90081-510.1016/0378-5173(86)90081-5 ↗
75. 10.1016/S1525-0016(02)90721-510.1016/S1525-0016(02)90721-5 ↗
76. 10.1073/pnas.123363410010.1073/pnas.1233634100 ↗
77. 10.1016/S0378-5173(97)04890-410.1016/S0378-5173(97)04890-4 ↗
78. 10.1002/jgm.18710.1002/jgm.187 ↗
79. 10.1016/j.addr.2003.12.00210.1016/j.addr.2003.12.002 ↗
80. 10.1016/S0889-8588(05)70004-610.1016/S0889-8588(05)70004-6 ↗
81. 10.1021/bc990025r10.1021/bc990025r ↗
82. 10.1089/1076327036072807110.1089/10763270360728071 ↗
83. Yang S · Part I. Traditional factors. Tissue Eng · 2001 · 7 · 679
84. 10.1038/nature0416510.1038/nature04165 ↗
85. 10.1016/S0939-6411(97)00150-110.1016/S0939-6411(97)00150-1 ↗